Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $75,583 | 3 | 78.0% |
| Food and Beverage | $13,774 | 748 | 14.2% |
| Travel and Lodging | $6,337 | 20 | 6.5% |
| Education | $1,250 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $76,901 | 8 | $0 (2024) |
| Medtronic Vascular, Inc. | $5,044 | 305 | $0 (2020) |
| Abbott Laboratories | $4,264 | 34 | $0 (2024) |
| Penumbra, Inc. | $2,165 | 3 | $0 (2023) |
| Boston Scientific Corporation | $1,625 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,580 | 104 | $0 (2024) |
| Endologix LLC | $675.17 | 4 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $434.51 | 39 | $0 (2024) |
| Amgen Inc. | $416.68 | 26 | $0 (2022) |
| Cardiovascular Systems Inc. | $308.27 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,214 | 44 | AngioDynamics, Inc. ($15,583) |
| 2023 | $32,986 | 49 | AngioDynamics, Inc. ($30,024) |
| 2022 | $30,966 | 58 | AngioDynamics, Inc. ($30,044) |
| 2021 | $2,649 | 79 | AngioDynamics, Inc. ($1,250) |
| 2020 | $1,470 | 86 | Medtronic Vascular, Inc. ($740.04) |
| 2019 | $2,295 | 137 | Medtronic Vascular, Inc. ($1,741) |
| 2018 | $2,566 | 144 | Medtronic Vascular, Inc. ($1,503) |
| 2017 | $5,799 | 175 | Abbott Laboratories ($1,954) |
All Payment Transactions
772 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Boston Scientific Corporation | ELUVIA (Device) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: ELUVIA_PI | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $579.95 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $163.23 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $163.23 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/31/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $65.82 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/31/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $65.38 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/31/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/08/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $15,583.33 | General |
| Category: ET | ||||||
| 07/03/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $754.78 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/21/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $152.78 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/21/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $126.17 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.35 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $41.25 | General |
| Category: Varithena_PI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 4,055 | 6,314 | $1.5M | $556,539 |
| 2022 | 45 | 3,571 | 5,640 | $1.3M | $497,035 |
| 2021 | 53 | 4,234 | 8,471 | $1.6M | $557,546 |
| 2020 | 53 | 5,352 | 17,212 | $2.3M | $807,298 |
All Medicare Procedures & Services
202 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 585 | 1,117 | $230,102 | $96,773 | 42.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 127 | 132 | $165,000 | $76,196 | 46.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 492 | 523 | $191,944 | $65,361 | 34.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 189 | 190 | $164,350 | $57,916 | 35.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 214 | 550 | $77,850 | $32,606 | 41.9% |
| 36247 | Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | Office | 2023 | 15 | 15 | $75,006 | $20,956 | 27.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 124 | 497 | $49,700 | $19,779 | 39.8% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 113 | 117 | $46,800 | $19,040 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 306 | $42,840 | $17,489 | 40.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 130 | 137 | $46,580 | $16,933 | 36.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 118 | 324 | $25,920 | $14,810 | 57.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 132 | 132 | $41,184 | $14,575 | 35.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 141 | 151 | $48,157 | $14,310 | 29.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 211 | 224 | $35,506 | $11,064 | 31.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 189 | 192 | $25,344 | $8,599 | 33.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 119 | 237 | $47,400 | $8,569 | 18.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 66 | 66 | $23,235 | $8,020 | 34.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 68 | 145 | $19,430 | $7,732 | 39.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 77 | 156 | $31,300 | $5,112 | 16.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 24 | 24 | $14,112 | $4,125 | 29.2% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 19 | 116 | $5,800 | $4,008 | 69.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 26 | $10,244 | $3,368 | 32.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 18 | 18 | $7,776 | $2,890 | 37.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 129 | 134 | $6,968 | $2,547 | 36.6% |
| 75716 | Review by radiologist of both arms or legs arteries image | Office | 2023 | 19 | 19 | $11,400 | $2,267 | 19.9% |
About Dr. Srinivasa Appakondu, M.D
Dr. Srinivasa Appakondu, M.D is a Cardiovascular Disease healthcare provider based in Hazard, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760421564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Srinivasa Appakondu, M.D has received a total of $96,944 in payments from pharmaceutical and medical device companies, with $18,214 received in 2024. These payments were reported across 772 transactions from 49 companies. The most common payment nature is "Long term medical supply or device loan" ($75,583).
As a Medicare-enrolled provider, Appakondu has provided services to 17,212 Medicare beneficiaries, totaling 37,637 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 202 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Hazard, KY
- Active Since 06/06/2006
- Last Updated 03/18/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1760421564
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $76,833
- HawkOne (Device) $2,364
- Indigo System (Device) $2,165
- AVEIR (Device) $2,080
- CardioMEMS HF System (Device) $1,698
- ENTRESTO (Drug) $1,500
- IN.PACT Admiral (Device) $1,489
- GENERAL - THERAPIES (Device) $1,215
- Endurant (Device) $669.57
- ELIQUIS (Drug) $543.05
- LifeVest (Device) $434.51
- Xience V coronary stent system (Device) $339.87
- XARELTO (Drug) $304.95
- Peripheral Orbital Atherectomy System (Device) $270.82
- BRILINTA (Drug) $226.68
- Corlanor (Drug) $224.94
- Impella (Device) $223.26
- Repatha (Biological) $191.74
- AFX (Device) $184.08
- SpiderFX (Device) $121.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.